Akoya Biosciences Profit Margin vs. Net Income
| AKYA Stock | USD 2.20 0.06 2.80% |
Akoya Biosciences Net Profit Margin |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.66 | 0.5827 |
|
|
For Akoya Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Akoya Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Akoya Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Akoya Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Akoya Biosciences over time as well as its relative position and ranking within its peers.
Akoya |
Akoya Biosciences' Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.16) | Revenue Per Share 1.889 | Quarterly Revenue Growth (0.01) | Return On Assets (0.18) | Return On Equity (1.28) |
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Akoya Biosciences Net Income vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth. Akoya Biosciences is rated below average in profit margin category among its peers. It also is rated below average in net income category among its peers . At present, Akoya Biosciences' Net Loss is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.Akoya Biosciences' Earnings Breakdown by Geography
Akoya Net Income vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Akoya Biosciences |
| = | (0.65) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Akoya Biosciences |
| = | (63.32 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Akoya Net Income Comparison
Akoya Biosciences is currently under evaluation in net income category among its peers.
Akoya Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Akoya Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Akoya Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Akoya Biosciences' change in net profit over the period of time. It can combine multiple indicators of Akoya Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.4 K | -5.7 K | |
| Net Interest Income | -5.2 M | -5.4 M | |
| Operating Income | -57.7 M | -60.6 M | |
| Net Loss | -71.4 M | -67.8 M | |
| Income Before Tax | -63.3 M | -66.4 M | |
| Total Other Income Expense Net | -5.6 M | -5.9 M | |
| Net Loss | -63.6 M | -60.4 M | |
| Net Loss | -63.3 M | -66.5 M | |
| Income Tax Expense | 40 K | 41.4 K | |
| Interest Income | 3.1 M | 3.3 M | |
| Non Operating Income Net Other | 163.3 K | 171.5 K | |
| Change To Netincome | 8.6 M | 4.6 M | |
| Net Loss | (1.43) | (1.50) | |
| Income Quality | 0.80 | 0.60 | |
| Net Income Per E B T | 1.00 | 1.10 |
Akoya Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Akoya Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Akoya Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Akoya Biosciences' important profitability drivers and their relationship over time.
Use Akoya Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akoya Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will appreciate offsetting losses from the drop in the long position's value.Akoya Biosciences Pair Trading
Akoya Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Akoya Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akoya Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akoya Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akoya Biosciences to buy it.
The correlation of Akoya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akoya Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akoya Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akoya Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Akoya Biosciences position
In addition to having Akoya Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Fabricated Products Thematic Idea Now
Fabricated Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Fabricated Products theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Fabricated Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
To fully project Akoya Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Akoya Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Akoya Biosciences' income statement, its balance sheet, and the statement of cash flows.